Impact of the COVID-19 pandemic on the incidence and mortality of hospital-onset bloodstream infection: a cohort study

被引:6
|
作者
Valik, John Karlsson [1 ,2 ]
Hedberg, Pontus [3 ]
Holmberg, Fredrik [1 ]
van der Werff, Suzanne Desiree [1 ]
Naucler, Pontus [1 ,2 ]
机构
[1] Karolinska Inst, Dept Med, Div Infect Dis, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden
[3] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden
关键词
COVID-19; adverse events; epidemiology and detection; infection control; nosocomial infections; healthcare quality improvement; BACTEREMIA; FUNGEMIA;
D O I
10.1136/bmjqs-2021-014243
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The COVID-19 pandemic burdens hospitals, but consequences for quality of care outcomes such as healthcare-associated infections are largely unknown. This cohort included all adult hospital episodes (n=186 945) at an academic centre between January 2018 and January 2021. Data were collected from the hospitals' electronic health record data repository. Hospital-onset bloodstream infection (HOB) was defined as any positive blood culture obtained >= 48 hours after admission classified based on microbiological and hospital administrative data. Subgroup analyses were performed with exclusion of potential contaminant bacteria. The cohort was divided into three groups: controls (prepandemic period), non-COVID-19 (pandemic period) and COVID-19 (pandemic period) based on either PCR-confirmed SARS-CoV-2 infections from respiratory samples or International Classification of Diseases 10th Revision diagnoses U071 and U72 at discharge. Adjusted incidence rate ratios (aIRR) and risk of death in patients with HOB were compared between the prepandemic and pandemic periods using Poisson and logistic regression. The incidence of HOB was increased for the COVID-19 group compared with the prepandemic period (aIRR 3.34, 95% CI 2.97 to 3.75). In the non-COVID-19 group, the incidence was slightly increased compared with prepandemic levels (aIRR 1.20, 95% CI 1.08 to 1.32), but the difference decreased when excluding potential contaminant bacteria (aIRR 1.15, 95% CI 1.00 to 1.31, p=0.04). The risk of dying increased for both the COVID-19 group (adjusted odds ratio (aOR) 2.44, 95% CI 1.75 to 3.38) and the non-COVID-19 group (aOR 1.63, 95% CI 1.22 to 2.16) compared with the prepandemic controls. These findings were consistent also when excluding potential contaminants. In summary, we observed a higher incidence of HOB during the COVID-19 pandemic, and the mortality risk associated with HOB was greater, compared with the prepandemic period. Results call for specific attention to quality of care during the pandemic.
引用
收藏
页码:379 / 382
页数:4
相关论文
共 50 条
  • [41] The incidence of nosocomial bloodstream infection and urinary tract infection in Australian hospitals before and during the COVID-19 pandemic: an interrupted time series study
    Brett G Mitchell
    Andrew J Stewardson
    Lucille Kerr
    John K Ferguson
    Stephanie Curtis
    Ljoudmila Busija
    Michael J Lydeamore
    Kirsty Graham
    Philip L Russo
    Antimicrobial Resistance & Infection Control, 12
  • [42] Impact of the COVID-19 pandemic on the cancer incidence in Germany
    Inwald, Elisabeth C.
    Klinkhammer-Schalke, Monika
    Mueller-Nordhorn, Jacqueline
    Voigtlaender, Sven
    Gerken, Michael
    Behrens, Bianca
    Fehm, Tanja N.
    Ortmann, Olaf
    GYNAKOLOGIE, 2024, 57 (01): : 3 - 8
  • [43] The incidence of nosocomial bloodstream infection and urinary tract infection in Australian hospitals before and during the COVID-19 pandemic: an interrupted time series study
    Mitchell, Brett G.
    Stewardson, Andrew J.
    Kerr, Lucille
    Ferguson, John K.
    Curtis, Stephanie
    Busija, Ljoudmila
    Lydeamore, Michael J.
    Graham, Kirsty
    Russo, Philip L.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2023, 12 (01)
  • [44] Incidence of bloodstream infections in patients with COVID-19: a retrospective cohort study of risk factors and outcomes
    Santos, Claudia Villatoro
    Fukushima, Elisa Akagi
    Zhao, Wei
    Sharma, Mamta
    Youssef, Dima
    Spzunar, Susan
    Levine, Miriam
    Saravolatz, Louis
    Bhargava, Ashish
    GERMS, 2022, 12 (02): : 253 - 261
  • [45] The impact of the COVID-19 pandemic on the incidence of herpes zoster
    Lecrenier, N.
    Parikh, R.
    Wang, C.
    Curran, D.
    Widenmaier, R.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [46] The Impact of a Pandemic COVID-19 on the Incidence of Borreliosis in Poland
    Piotrowski, Mariusz
    Rymaszewska, Anna
    ACTA PARASITOLOGICA, 2022, 67 (02) : 1007 - 1009
  • [47] The impact of infectious diseases department on the incidence of hospital-onset bacteremia and fungemia at a tertiary care center: a retrospective cohort study
    Kawamoto, Yuya
    Takamatsu, Akane
    Matsui, Kenjiro
    Doi, Yohei
    Honda, Hitoshi
    INFECTION CONTROL & HOSPITAL EPIDEMIOLOGY, 2025,
  • [48] IMPACT OF THE COVID-19 PANDEMIC ON THE INCIDENCE OF DENGUE IN PERU
    Failoc-Rojas, Virgilio E.
    Plasencia-Duenas, Rubi
    Cordova-Hernandez, Jorge G.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2021, 105 (05): : 197 - 197
  • [49] The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections
    Driedger, Matt
    Daneman, Nick
    Brown, Kevin
    Gold, Wayne L.
    Jorgensen, Sarah C. J.
    Maxwell, Colleen
    Schwartz, Kevin L.
    Morris, Andrew M.
    Thiruchelvam, Deva
    Langford, Bradley
    Leung, Elizabeth
    Macfadden, Derek
    Babiker, Ahmed
    MICROBIOLOGY SPECTRUM, 2023,
  • [50] The Impact of the COVID-19 Pandemic on Antimicrobial Resistance and Management of Bloodstream Infections
    Petrakis, Vasilios
    Panopoulou, Maria
    Rafailidis, Petros
    Lemonakis, Nikolaos
    Lazaridis, Georgios
    Terzi, Irene
    Papazoglou, Dimitrios
    Panagopoulos, Periklis
    PATHOGENS, 2023, 12 (06):